123 related articles for article (PubMed ID: 20299220)
1. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP
Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220
[TBL] [Abstract][Full Text] [Related]
2. Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.
Tan Q; Ogawa AM; Raghoobar SL; Wisniewski D; Colwell L; Park YW; Young K; Hermes JD; Dininno FP; Hammond ML
Bioorg Med Chem Lett; 2011 Jul; 21(14):4363-5. PubMed ID: 21664132
[TBL] [Abstract][Full Text] [Related]
3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
4. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H
Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
[TBL] [Abstract][Full Text] [Related]
5. Nanomolar inhibitors of AmpC beta-lactamase.
Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
Brown S; Young HK; Amyes SG
Clin Microbiol Infect; 2005 Jan; 11(1):15-23. PubMed ID: 15649299
[TBL] [Abstract][Full Text] [Related]
7. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
[TBL] [Abstract][Full Text] [Related]
8. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
[TBL] [Abstract][Full Text] [Related]
9. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.
Chen H; Blizzard TA; Kim S; Wu J; Young K; Park YW; Ogawa AM; Raghoobar S; Painter RE; Wisniewski D; Hairston N; Fitzgerald P; Sharma N; Scapin G; Lu J; Hermes J; Hammond ML
Bioorg Med Chem Lett; 2011 Jul; 21(14):4267-70. PubMed ID: 21676616
[TBL] [Abstract][Full Text] [Related]
10. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei.
Yang Z; Niu Y; Le Y; Ma X; Qiao C
Phytomedicine; 2010 Feb; 17(2):139-41. PubMed ID: 19747808
[TBL] [Abstract][Full Text] [Related]
13. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
Perumal SK; Adediran SA; Pratt RF
Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
[TBL] [Abstract][Full Text] [Related]
14. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.
Merkier AK; Centrón D
Int J Antimicrob Agents; 2006 Aug; 28(2):110-3. PubMed ID: 16844350
[TBL] [Abstract][Full Text] [Related]
15. Detection of plasmid-mediated class C beta-lactamases.
Doi Y; Paterson DL
Int J Infect Dis; 2007 May; 11(3):191-7. PubMed ID: 17339123
[TBL] [Abstract][Full Text] [Related]
16. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Moloughney JG; D Thomas J; Toney JH
FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
18. [Activity of beta-lactamase inhibitors against Acinetobacter baumannii].
Fernández Cuenca F
Rev Esp Quimioter; 1998 Dec; 11(4):384-5. PubMed ID: 10336325
[No Abstract] [Full Text] [Related]
19. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
20. Metallo-beta-lactamase inhibitors: promise for the future?
Toney JH; Moloughney JG
Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
